IndraLab

Statements


| 1 1

eidos
"Therefore , JAK1 diminishment by Na + / K + - ATPase inhibitors / antagonists may not arise from their targeting of Na + / K + - ATPase ; and Na + / K + - ATPase independent JAK1 diminishment by natural cardenolides and bufadienolides could be the basis for their clinical benefits in the diseases they are used to treat ."
| PMC

reach
"Therefore, JAK1 diminishment by Na + / K + -ATPase inhibitors and antagonists may not arise from their targeting of Na + / K + -ATPase; and Na + / K + -ATPase independent JAK1 diminishment by natural cardenolides and bufadienolides could be the basis for their clinical benefits in the diseases they are used to treat."
| PMC